[Randomized controlled study of very low-dose Ara-C versus low-dose aclarubicin for the treatment of myelodysplastic syndrome].
作者信息
Shibuya T, Nagafuji H, Mizuno S, Harada M
出版信息
Rinsho Ketsueki. 1996 Sep;37(9):782-4.
PMID:8914462
Abstract
摘要
相似文献
1
2
Low-dose Ara-C in the treatment of myelodysplastic syndromes.小剂量阿糖胞苷治疗骨髓增生异常综合征
Bone Marrow Transplant. 1989 Dec;4 Suppl 3:26-7.
3
[Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].[70岁以上急性髓系白血病。小剂量阿糖胞苷治疗的经验]
Sangre (Barc). 1998 Feb;43(1):35-9.
4
Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
J Chemother. 1989 Jul;1(4 Suppl):1276-8.
5
Long-term case study of myelodysplastic syndrome in a dog.犬骨髓增生异常综合征的长期病例研究。
J Am Anim Hosp Assoc. 1999 Nov-Dec;35(6):475-81. doi: 10.5326/15473317-35-6-475.
6
Anti-Fas IgM monoclonal antibody enhances apoptosis induced by low-dose cytosine arabinoside.
Anticancer Res. 1999 Jan-Feb;19(1A):197-204.
7
[Clinical effect of low-dose Ara-c and its mechanism of antileukemic action].[小剂量阿糖胞苷的临床疗效及其抗白血病作用机制]
Rinsho Ketsueki. 1986 Aug;27(8):1482-7.
8
[Successful treatment of acute non-lymphoblastic leukemia from myelodysplastic syndrome by combination of human macrophage colony-stimulating factor (M-CSF) and low dose cytosine arabinoside: M-CSF-induced proliferation and tyrosine phosphorylation in leukemic blasts].人巨噬细胞集落刺激因子（M-CSF）与小剂量阿糖胞苷联合治疗骨髓增生异常综合征所致急性非淋巴细胞白血病：M-CSF诱导白血病原始细胞增殖及酪氨酸磷酸化
Rinsho Ketsueki. 1996 Nov;37(11):1259-64.
9
Low-dose cytarabine-induced hepatic and renal dysfunction in a patient with myelodysplastic syndrome.低剂量阿糖胞苷诱发骨髓增生异常综合征患者的肝肾功能障碍。
Anticancer Drugs. 1999 Mar;10(3):289-91. doi: 10.1097/00001813-199903000-00006.
Zotero 插件